When Will the Wegovy Pill Be Available in the UK?

The approval is done, so what is left to decide?

For most people searching this question, the biggest hurdle was uncertainty. That uncertainty is now resolved. The MHRA granted marketing authorisation on 11 June 2026, and Wegovy tablets moved from a future prospect to a real, licensed medicine on that date. The question has shifted from when to whether this is right for you, and that is a more useful question to sit with.

Oral semaglutide for weight loss works through the same GLP-1 receptor pathway as the weekly injection, but it arrives via a tablet co-formulated with an absorption enhancer called SNAC. That formulation change is what makes swallowing a pill achieve a meaningful blood level of semaglutide, and if you are wondering whether semaglutide is available in pill form, the short answer is that it now is, as a licensed medicine in the UK. The licensed schedule runs from 1.5 mg once daily up to a 25 mg maintenance dose, with the prescriber guiding each step. For more on how the tablet compares to what came before it, the oral semaglutide availability guide covers the differences in practical terms.

The trial evidence comes from the OASIS 4 study, a phase 3 trial of 307 adults with obesity or overweight and at least one weight-related condition, run over 64 weeks. Average weight loss was around 13.6% compared with roughly 2.4% on placebo; among participants who stayed fully adherent to treatment the figure reached approximately 17%. Those numbers are meaningful, though as with any prescription medicine, individual results vary and a prescriber will weigh your full clinical picture before recommending a dose or a product.

Who the Wegovy tablet is licensed for, and what the NHS situation actually is

The UK licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. That mirrors the injection's broad eligibility framework. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance, your prescriber will apply the correct threshold during assessment.

One point worth being clear about: NHS availability is a separate question from MHRA approval. Approval tells us the medicine is safe and effective enough to prescribe; NHS commissioning requires a NICE technology appraisal, which takes additional time and has not yet been initiated for the Wegovy tablet. At the time of writing, this medicine is available in the UK only through private prescription. If you are curious about the broader availability picture for Wegovy in pill form, that page covers commissioning timelines in more detail.

Rybelsus (also oral semaglutide) is occasionally confused with the Wegovy tablet, so it is worth naming the distinction plainly. Rybelsus carries a diabetes licence and uses doses of 3 mg, 7 mg and 14 mg; the Wegovy weight-loss tablet uses an entirely different schedule (1.5 mg, 4 mg, 9 mg, 25 mg) and holds a separate weight-management authorisation. They are not interchangeable, and a prescription for one does not cover the other.

How you actually take it, and why the timing matters more than people expect

The tablet needs to be taken first thing in the morning, on a completely empty stomach, with a small amount of plain water (no more than around 120 ml). After swallowing, you wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medicines. Coffee counts. The kettle can wait. This is not a rough guideline, absorption depends on it, and cutting that window short consistently can reduce how well the medicine works. Full instructions are in the guidance on when to take semaglutide tablets, and your prescriber will go over this at consultation too.

The storage difference from the injection is genuinely useful. No fridge required. The tablet travels easily, which matters if your schedule involves hotels, long trips, or the kind of week where the fridge is the first thing that gets disrupted. People who found managing refrigerated pens awkward (whether at work or away from home) often find this a practical reason to consider the tablet route.

If timing is on your mind for other reasons (payday timing, a bank holiday disrupting a delivery, a Monday start) it is worth knowing that orders placed before 12pm Monday to Friday are dispatched the same day once clinically approved, arriving free via tracked DPD the next working day. Planning around that is straightforward. Details on what the treatment involves are on the semaglutide tablets page.

Side effects, the prescription process, and what to check before you start

The most commonly reported side effects in the OASIS 4 trial were gastrointestinal: nausea, vomiting, diarrhoea and constipation featured most often, affecting around 74% of participants on oral semaglutide versus 42% on placebo. That gap sounds wide, but most effects were mild to moderate and tended to ease as the body adjusted, particularly after each dose step settled. Symptoms are typically most noticeable in the first week or two at a new dose level.

Serious effects are less common but worth knowing. The MHRA has highlighted acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines: severe stomach pain that extends to the back, with or without vomiting, is a signal to seek urgent medical attention rather than wait it out. Reporting suspected side effects through the MHRA Yellow Card scheme helps the regulator monitor safety across the population using these medicines.

Oral semaglutide is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. It is not licensed for under-18s. A prescriber at nume reviews every consultation personally (not a decision tree, not automated scoring) and will flag any contraindications or interactions before anything is prescribed. If you have questions before starting, the FAQs cover common ones, or you can reach the clinical team via the contact page. When you are ready to take the next step, starting your free consultation is the right place to begin.